BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22678306)

  • 1. Genetic analysis of short children with apparent growth hormone insensitivity.
    Wit JM; van Duyvenvoorde HA; Scheltinga SA; de Bruin S; Hafkenscheid L; Kant SG; Ruivenkamp CA; Gijsbers AC; van Doorn J; Feigerlova E; Noordam C; Walenkamp MJ; Claahsen-van de Grinten H; Stouthart P; Bonapart IE; Pereira AM; Gosen J; Delemarre-van de Waal HA; Hwa V; Breuning MH; Domené HM; Oostdijk W; Losekoot M
    Horm Res Paediatr; 2012; 77(5):320-33. PubMed ID: 22678306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of insulin-like growth factor deficiency.
    Wit JM; Oostdijk W; Losekoot M
    Endocr Dev; 2012; 23():30-41. PubMed ID: 23182818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature.
    Domené HM; Scaglia PA; Jasper HG
    Pediatr Endocrinol Rev; 2010 Jun; 7(4):339-46. PubMed ID: 20679994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation.
    Vidarsdottir S; Walenkamp MJ; Pereira AM; Karperien M; van Doorn J; van Duyvenvoorde HA; White S; Breuning MH; Roelfsema F; Kruithof MF; van Dissel J; Janssen R; Wit JM; Romijn JA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3482-5. PubMed ID: 16787985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MECHANISMS IN ENDOCRINOLOGY: Novel genetic causes of short stature.
    Wit JM; Oostdijk W; Losekoot M; van Duyvenvoorde HA; Ruivenkamp CA; Kant SG
    Eur J Endocrinol; 2016 Apr; 174(4):R145-73. PubMed ID: 26578640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic evaluation of short stature.
    Wit JM; Kiess W; Mullis P
    Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):1-17. PubMed ID: 21396571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI).
    Ramírez L; Sanguineti N; Scaglia P; Keselman A; Ballerini MG; Karabatas L; Landi E; Castro J; Domené S; Pennisi P; Jasper H; Rey RA; Vázquez M; Domené H; Bergadá I; Gutiérrez M
    Growth Horm IGF Res; 2020 Feb; 50():61-70. PubMed ID: 31902742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation sequencing-based mutation screening of 86 patients with idiopathic short stature.
    Hattori A; Katoh-Fukui Y; Nakamura A; Matsubara K; Kamimaki T; Tanaka H; Dateki S; Adachi M; Muroya K; Yoshida S; Ida S; Mitani M; Nagasaki K; Ogata T; Suzuki E; Hata K; Nakabayashi K; Matsubara Y; Narumi S; Tanaka T; Fukami M
    Endocr J; 2017 Oct; 64(10):947-954. PubMed ID: 28768959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I in human growth: lessons from defects in the GH-IGF-I axis.
    Hwa V; Fang P; Derr MA; Fiegerlova E; Rosenfeld RG
    Nestle Nutr Inst Workshop Ser; 2013; 71():43-55. PubMed ID: 23502138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-exome sequencing gives additional benefits compared to candidate gene sequencing in the molecular diagnosis of children with growth hormone or IGF-1 insensitivity.
    Shapiro L; Chatterjee S; Ramadan DG; Davies KM; Savage MO; Metherell LA; Storr HL
    Eur J Endocrinol; 2017 Dec; 177(6):485-501. PubMed ID: 28870985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical defects resulting in growth hormone insensitivity.
    Wit JM; de Luca F
    Growth Horm IGF Res; 2016 Jun; 28():57-61. PubMed ID: 26670721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic disorders of GH action pathway.
    Domené HM; Fierro-Carrión G
    Growth Horm IGF Res; 2018 Feb; 38():19-23. PubMed ID: 29249625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of clinical manifestations and genetic mutations in a child with Laron syndrome].
    Chang GY; Chen SK; Gu XF; Gong ZW; Zhang QG
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):930-3. PubMed ID: 24495765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous IGFALS gene variants in idiopathic short stature and normal children: impact on height and the IGF system.
    Domené HM; Scaglia PA; Martínez AS; Keselman AC; Karabatas LM; Pipman VR; Bengolea SV; Guida MC; Ropelato MG; Ballerini MG; Lescano EM; Blanco MA; Heinrich JJ; Rey RA; Jasper HG
    Horm Res Paediatr; 2013; 80(6):413-23. PubMed ID: 24335034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels, and hyperinsulinemia.
    Heath KE; Argente J; Barrios V; Pozo J; Díaz-González F; Martos-Moreno GA; Caimari M; Gracia R; Campos-Barros A
    J Clin Endocrinol Metab; 2008 May; 93(5):1616-24. PubMed ID: 18303074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic characterisation of a cohort of children clinically labelled as GH or IGF1 insensitive: diagnostic value of serum IGF1 and height at presentation.
    Storr HL; Dunkel L; Kowalczyk J; Savage MO; Metherell LA
    Eur J Endocrinol; 2015 Feb; 172(2):151-61. PubMed ID: 25411237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHOX gene variants: growth hormone/insulin-like growth factor-1 status and response to growth hormone treatment.
    Shapiro S; Klein GW; Klein ML; Wallach EJ; Fen Y; Godbold JH; Rapaport R
    Horm Res Paediatr; 2015; 83(1):26-35. PubMed ID: 25659810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of a new acid-labile subunit (IGFALS) heterozygous mutation: anthropometric and biochemical characterization and response to growth hormone administration.
    Grandone A; Miraglia del Giudice E; Cirillo G; Abbondanza C; Cioffi M; Romano T; Micillo F; Marzuillo P; Perrone L
    Horm Res Paediatr; 2014; 81(1):67-72. PubMed ID: 24356109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in IGFALS, c.380T>C (p.L127P), associated with short stature, delayed puberty, osteopenia and hyperinsulinaemia in two siblings: insights into the roles of insulin growth factor-1 (IGF1).
    Hess O; Khayat M; Hwa V; Heath KE; Teitler A; Hritan Y; Allon-Shalev S; Tenenbaum-Rakover Y
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):838-44. PubMed ID: 23488611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.